Advertisement
Introduction| Volume 4, SUPPLEMENT 3, S99-S100, January 2004

New Perspectives with Antimetabolites in the Management of Breast Cancer

  • Joyce A. O'Shaughnessy
    Correspondence
    Address for correspondence: Joyce A. O'Shaughnessy, MD, Baylor Charles A. Sammons Cancer Center, Collins Bldg, 5th Floor, 3535 Worth St, Dallas, TX 75246
    Affiliations
    Baylor Charles A. Sammons Cancer Center, Dallas, TX
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fine RL
        • Fogelman DR
        • Sherman W
        • et al.
        The GTX regimen: a biochemically synergistic combination for advanced pancreatic cancer (PC).
        Proc Am Soc Clin Oncol. 2003; 22 (Abstract #1129).: 281